医学
危险系数
接收机工作特性
比例危险模型
内科学
四分位数
胃肠病学
置信区间
生存分析
对数秩检验
外科
作者
Jie Liu,Pengfei Wang,Jiajun Ji
出处
期刊:Shock
[Lippincott Williams & Wilkins]
日期:2025-03-03
卷期号:63 (6): 863-869
被引量:1
标识
DOI:10.1097/shk.0000000000002574
摘要
ABSTRACT: Background: Neutrophil percentage-to-albumin ratio (NPAR) has been proven to correlate with the poor prognosis of various diseases. This study aims at investigating the prognostic value of NPAR for septic cholangitis patients from Medical Information Mart Intensive Care IV database. Methods: Overall, 329 adult septic cholangitis patients were retrospectively included, of whom 82 experienced deaths within 30 days. Cox regression, restricted cubic spline, and Kaplan-Meier curves were employed to evaluate the association between NPAR and 30-day mortality. Hazard ratio (HR) and 95% confidential interval (95% CI) were calculated. Receiver operating characteristic curves and integrated discrimination improvement analysis were utilized to assess the predictive efficacy of NPAR. Results: NPAR was significantly associated with 30-day mortality in multivariable Cox analysis (HR = 1.52, 95% CI = 1.16-1.99, P = 0.003). Kaplan-Meier curves indicated NPAR in the second quartile (range from 2.55-2.93) demonstrated the lowest mortality (log-rank test: P < 0.001). RCS curves showed a U-shaped relationship between NPAR and 30-day mortality, and an inflection point of appropriately 2.73 was discovered. HRs and 95% CIs on the left and right sides of the inflection point, were 0.299 (0.114-0.781, P = 0.014) and 1.955 (1.362-2.807, P < 0.001), respectively. NPAR exhibited a moderate Receiver operating characteristic (0.668) for the prediction of 30-day mortality. Importantly, addition of the NPAR into illness score models can significantly improve the predictive ability. Conclusions: A U-shaped nonlinear association was observed between NPAR and 30-day all-cause mortality in septic cholangitis patients. NPAR emerged as a potential marker for the prognosis of critical cholangitis patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI